PRLD
#3198
Prelude Therapeutics Incorporated - Common Stock
4.4 4 USD
-0.08%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-7.69%
Monthly Change
-3.48%
6 month change
+95.59%
Year Change
+448.15%
Previous Close
4.8 1
Open
4.4 4
Low
4.4 4
High
4.4 4
Volume
33
Financials
- Market Capitalization 353.63 M
- Employee 79
- Founded 2016
- CEO N/A
- Website www.preludetx.com
- Headquarter Delaware, United States
- FIGI BBG00K7JY2Q6
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-2.25
Price to sales ratio
18.38
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3166 |  LXEO Lexeo Therapeutics, Inc. - Common Stock | 4.65 USD | -3.53% | -1.06% | +2.65% | +3.33% | 365.13 M USD | ||
| 3181 |  VNDA Vanda Pharmaceuticals Inc. - Common Stock | 6.00 USD | -3.85% | -4.46% | +1.18% | +8.50% | 360.81 M USD | ||
| 3202 |  FATE Fate Therapeutics, Inc. - Common Stock | 3.02 USD | -2.58% | -0.33% | +44.50% | +162.61% | 352.01 M USD | ||
| 3215 |  HELP Cybin Inc. - Common Stock | 6.70 USD | -2.47% | +14.92% | +52.27% | -25.31% | 345.93 M USD |
Frequently asked questions about Prelude Therapeutics Incorporated - Common Stock
What is the Prelude Therapeutics Incorporated - Common Stock stock price today?
The current price of Prelude Therapeutics Incorporated - Common Stock (PRLD) is 4.44. Over the past 24 hours, the stock has changed by -7.69%. Follow the PRLD chart for real-time price dynamics.
What is the stock ticker of Prelude Therapeutics Incorporated - Common Stock?
Prelude Therapeutics Incorporated - Common Stock trades under the ticker PRLD. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Prelude Therapeutics Incorporated - Common Stock stock going up?
PRLD has changed by -11.55% over the last week, -3.48% over the last month, and +448.15% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Prelude Therapeutics Incorporated - Common Stock net income for the last quarter?
Prelude Therapeutics Incorporated - Common Stock reported net income of -10.38 M for the last quarter. The previous quarter showed -16.46 M, which means net income changed by +36.90%.
How many employees does Prelude Therapeutics Incorporated - Common Stock have?
As of the latest available data, Prelude Therapeutics Incorporated - Common Stock has 79 employees. Workforce size can provide additional context about the company's scale and operations.
What is Prelude Therapeutics Incorporated - Common Stock EBITDA?
Prelude Therapeutics Incorporated - Common Stock EBITDA is -13.79 M, and its EBITDA margin is -301%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Prelude Therapeutics Incorporated - Common Stock stock?
You can buy Prelude Therapeutics Incorporated - Common Stock (PRLD) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Prelude Therapeutics Incorporated - Common Stock stock?
Investing in Prelude Therapeutics Incorporated - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the PRLD chart and related analysis on metatrader.com as part of your research.